Li Lai

1.6k citations

43 papers · 1.2k indexed · h-index 18

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research

Papers in ⓘ

Molecular Biology 26
- Angiogenesis and VEGF in Cancer 4
- Wnt/β-catenin signaling in development and cancer 3
- Epigenetics and DNA Methylation 3
- Natural product bioactivities and synthesis 2
Oncology 7

Co-authors: Mingyao Liu (10 shared papers)Zhengfang Yi (7 shared papers)Yanmin Dong (4 shared papers)Yihua Chen (4 shared papers)Yeong‐Hau H. Lien (2 shared papers)John P. Cooke (9 shared papers)Dong Zhai (3 shared papers)Dali Li (3 shared papers)
Journals: Carcinogenesis (2 papers)OncoTargets and Therapy (2 papers)Circulation (2 papers)The International Journal of Advanced Manufacturing Technology (1 paper)Nature Communications (1 paper)
Partner nations: United States China

In The Last Decade

Li Lai

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Li Lai

Since Specialization

Citations

This map shows the geographic impact of Li Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lai more than expected).

Fields of papers citing papers by Li Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lai. The network helps show where Li Lai may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Lai Line = papers co-authored together Li Lai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway Carcinogenesis ·Yujuan Dong, Bojing Lu, Xiongwen Zhang, Jian Zhang, Li Lai, Dongliang Li, Yuanyuan Wu, Y. Song, Jian Luo, Xuehai Pang, Zhengfang Yi, Mingyao Liu	2010	145
2	Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer Cancer Research ·Junchen Liu, Guo Chen, Zezhen Liu, Shaoyou Liu, Zhiduan Cai, Pan You, Yuepeng Ke, Li Lai, Yun Huang, Hongchang Gao, Liangcai Zhao, Hélène Pelicano, Peng Huang, Wallace L. McKeehan, Chin‐Lee Wu, Cong Wang, Weide Zhong, Fen Wang	2018	88
3	Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion Breast Cancer Research and Treatment ·Tao Zhang, Jingjie Li, Yanmin Dong, Dong Zhai, Li Lai, Fujun Dai, Huayun Deng, Yihua Chen, Mingyao Liu, Zhengfang Yi	2012	86
4	Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2 Stem Cells ·Ying Wang, Jie Dong, Dali Li, Li Lai, Stefan Siwko, Yi Li, Mingyao Liu	2013	81
5	Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor‐2 British Journal of Pharmacology ·Li Lai, Junchen Liu, Dong Zhai, Qingxiang Lin, Lijun He, Yanmin Dong, Jing Zhang, Binbin Lu, Yihua Chen, Zhengfang Yi, Mingyao Liu	2011	71
6	A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells PLoS ONE ·Fujun Dai, Yihua Chen, Yajuan Song, Li Huang, Dong Zhai, Yanmin Dong, Li Lai, Tao Zhang, Dali Li, Xiufeng Pang, Mingyao Liu, Zhengfang Yi	2012	70
7	Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2‐mediated JAK/STAT3 signaling in endothelial cell International Journal of Cancer ·Xiaoli Zhang, Yajuan Song, Yuanyuan Wu, Yanmin Dong, Li Lai, Jing Zhang, Binbin Lu, Fujun Dai, Lijun He, Mingyao Liu, Zhengfang Yi	2011	70
8	Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. Journal of Clinical Investigation ·Li Lai, Darwin Chan, Robert P. Erickson, Shu-Yeh Hsu, Yeong‐Hau H. Lien	1998	67
9	LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells The FASEB Journal ·Zhiying Yue, Zengjin Yuan, Li Zeng, Ying Wang, Li Lai, Jing Li, Peng Sun, Xiwen Xue, Junyi Qi, Zhengfeng Yang, Yansen Zheng, Yuanzhang Fang, Dali Li, Stefan Siwko, Yi Li, Jian Luo, Mingyao Liu	2017	64
10	Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro Infection and Immunity ·Pearl Toy, Li Lai, Thomas A. Drake, Michiel A. J. van de Sande	1985	57
11	Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression Advanced Science ·Qingxiang Lin, Yuan He, Xue Wang, Yong Zhang, Meichun Hu, Weikai Guo, Yundong He, Tao Zhang, Li Lai, Zhenliang Sun, Zhengfang Yi, Mingyao Liu, Yihua Chen	2020	42
12	Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage Circulation ·Li Lai, Erin L. Reineke, Dale J. Hamilton, John P. Cooke	2018	38
13	1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway Carcinogenesis ·Xuehai Pang, Li Zhang, Li Lai, Jiahao Chen, Yuanyuan Wu, Zhengfang Yi, Jian Zhang, Wenrui Qu, Bharat B. Aggarwal, Mingyao Liu	2011	28
14	Liposome-mediated gene transfer into the tubules. PubMed ·Yeong Hau H. Lien, Li Lai	1997	26
15	Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment Precision Clinical Medicine ·Ping Tan, Ming Shi, Li Lai, Zhuang Tang, Nan Xie, Hang Xu, Qiang Wei, Xiaoyu Zhang, Lu Yang, Lily Wu	2018	22
16	<p>LncRNA LINC01116 Promotes the Development of Colorectal Cancer by Targeting miR-9-5p/STMN1</p> OncoTargets and Therapy ·Chongyao Bi, Hongshuai Cui, Haijing Fan, Li Lai	2020	21
17	<p>Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor</p> OncoTargets and Therapy ·Peng Jiang, Mingzhu Jia, Jing Hu, Zhen Huang, Ying Deng, Li Lai, Shanshan Ding, Zhuoying Hu	2020	21
18	Gene therapy for renal diseases. PubMed ·Yeong‐Hau H. Lien, Li Lai	1997	19
19	Inhibition of Beclin 1 Expression Enhances Cisplatin-Induced Apoptosis Through a Mitochondrial-Dependent Pathway in Human Ovarian Cancer SKOV3/DDP Cells Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Yang Sun, Jiahua Liu, Long Jin, Yuxia Sui, Li Lai, Yin Yang	2014	17
20	Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China BMC Cancer ·Bo Chen, Dehong Cao, Li Lai, Jianbing Guo, Zeyu Chen, Yin Huang, Shi Qiu, Tianhai Lin, Yue Gou, Na Ma, Lu Yang, Liangren Liu, Qiang Wei	2020	16

About Li Lai

Li Lai is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Physiology, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cell Image Analysis Techniques (2 papers), Natural product bioactivities and synthesis (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Toxicology (98 citations), Cancer Research (212 citations), Molecular Biology (721 citations), Oncology (217 citations) and Genetics (169 citations). Li Lai has collaborated with scholars based in United States and China. Frequent co-authors include Mingyao Liu, Zhengfang Yi, Yanmin Dong, Yihua Chen, Yeong‐Hau H. Lien, John P. Cooke, Dong Zhai, Dali Li, Fujun Dai and Yuanyuan Wu. Their work appears in journals such as Carcinogenesis, OncoTargets and Therapy, Circulation, The International Journal of Advanced Manufacturing Technology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact